SCHEMBL10094195

SCHEMBL10094195

CC(C)c1ccccc1Nc1cccnn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GOT1 P17174 1/20 0.43
▸ CCR4 P51679 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ PIK3CA P42336 1/20 0.41
▸ PIK3CB P42338 1/20 0.41
▸ PIK3CG P48736 1/20 0.41
▸ MEN1 O00255 1/20 0.39
▸ MAPK10 P53779 1/20 0.39
▸ GFER P55789 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ POLB P06746 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ JAK2 O60674 1/20 0.37
▸ JAK1 P23458 1/20 0.37
▸ TYK2 P29597 1/20 0.37
▸ JAK3 P52333 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17662027 0.80 FFAR2 (0.43) GOT1MEN1KMT2ANPC1ALDH1A1
SCHEMBL10094163 0.79 MEN1 (0.66) CCR4L3MBTL1PIK3CAPIK3CBPIK3CG
SCHEMBL10094181 0.75 ALDH1A1 (0.53) CCR4L3MBTL1PIK3CAPIK3CBPIK3CG
SCHEMBL3958491 0.75 L3MBTL1 (0.57) CCR4L3MBTL1PIK3CAPIK3CBPIK3CG
SCHEMBL10094185 0.72 XIAP (0.45) CCR4L3MBTL1PIK3CAPIK3CBPIK3CG
SCHEMBL10094184 0.72 HPGD (0.48) CCR4L3MBTL1PIK3CAPIK3CBPIK3CG
SCHEMBL10094162 0.72 PIK3CA (0.58) CCR4L3MBTL1PIK3CAPIK3CBPIK3CG
SCHEMBL10094167 0.70 POLB (0.49) CCR4L3MBTL1PIK3CAPIK3CBPIK3CG
SCHEMBL8326088 0.70 AURKA (0.50) GOT1L3MBTL1MEN1MAPK10GFER
SCHEMBL10094165 0.70 HTT (0.49) CCR4L3MBTL1PIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148535-B2 Potassium channel inhibitors MERCK SHARP & DOHME CORP. (US) 2012-04-03 — — US disclosed
US-8148535-B2 Potassium channel inhibitors MERCK SHARP & DOHME CORP. (US) 2012-04-03 — — US disclosed
US-20090233897-A1 Potassium Channel Inhibitors MERCK SHARP & DOHME CORP. 2009-09-17 — — US disclosed
US-20090233897-A1 Potassium Channel Inhibitors MERCK SHARP & DOHME CORP. 2009-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233897-A1 Potassium Channel Inhibitors KCNJ2, KCNQ2, KCNH2 GOT1 3977/4885CCR4 4852/4885L3MBTL1 519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback